ICER Study On Coverage 'Fairness' Could Inform Manufacturer Pricing vs Benefit Design Debate

 
• By Cathy Kelly
  
ICER 'Fair Access' Study Will Focus On Prior Authorization Requirements
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet